Skip to content

Effect of Hyaluronic acid injection in treatment of Plantar fasciitis

Comparison of effectiveness between Corticosteroid and Hyaluronic acid injection in treatment of patients with Plantar fasciitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130523013442N26
Enrollment
40
Registered
2018-09-18
Start date
2018-07-25
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar fasciitis. Plantar fascial fibromatosis

Interventions

Intervention 1: Intervention group: Injection of 1ml high molecular weight Hyalorunic acid 2% (trade name "Viscor", 2500-3500 kDa, Fermentation source, 50 mg in 2.5 cc, Made in Iran) and 1 ml Lidocain

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with diagnosis of Plantar fasciitis who are visited at the Physical medicine & Rehabilitation clinic of Shahid Modarres hospital Age between 25-60 years old Having the pain since 3 months ago or more Not responding to initial conservative treatments such as shoe insoles, excercise and NSAIDs Willing to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy Taking Corticosteroids or NSAIDs (oral route) in past 3 weeks or injecting corticosteroids at the site of plantar fascia in past 6 months History of vasovagal syncope Being hemodynamically unstable Recent skin or soft tissue infection at the site of injection Heel pain due to neuropathy or radiculopathy History of Diabetes Mellitus Fracture in surrounding bones Having other diseases which can cause heel pain such as Ankylosing Spondylitis or other inflammatory disorders History of surgery at Plantar Fascia

Design outcomes

Primary

MeasureTime frame
Heel pain. Timepoint: Before intervention and 2 & 6 months after injection. Method of measurement: Visual Analogue Scale questionnaire.

Secondary

MeasureTime frame
Pressure Pain Threshold. Timepoint: Before intervention and 2 & 6 months after injection. Method of measurement: Algometer.;Effect of the pain on function. Timepoint: Before intervention and 2 & 6 months after injection. Method of measurement: Foot and Ankle Ability Measure (FAAM) questionnaire.;Plantar fascia thickness in vertical and horizontal sections. Timepoint: Before intervention and 2 & 6 months after injection. Method of measurement: Ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahtab Darvish

Shahid Beheshti University of Medical Sciences

mahtab.darvish@sbmu.ac.ir+98 21 2283 2343

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026